This inventor holds 1 USPTO granted patent. Top assignee: Arcus Biosciences, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Daniel M DiRenzo
Introduction
Daniel M DiRenzo is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on utilizing an identified adenosine fingerprint to treat cancer, showcasing his commitment to advancing medical science.
Latest Patents
Daniel M DiRenzo holds a patent for the "Treatment of cancer utilizing an identified adenosine fingerprint." This patent outlines methods for treating cancer in subjects by assessing the blood concentration and enzymatic activity of adenosine machinery proteins. The methods also include evaluating tumor expression levels of these proteins. The therapeutic agents involved target the extracellular production of adenosine and antagonize the activation of adenosine receptors.
Career Highlights
DiRenzo is currently associated with Arcus Biosciences, Inc., where he continues to work on groundbreaking cancer therapies. His dedication to research and innovation has positioned him as a key figure in the fight against cancer.
Collaborations
Some of his notable coworkers include Amy Elizabeth Anderson and Matthew J Walters. Their collaborative efforts contribute to the advancement of cancer treatment methodologies.
Conclusion
Daniel M DiRenzo's work exemplifies the impact of innovative thinking in the medical field. His patent and ongoing research at Arcus Biosciences, Inc. highlight his dedication to improving cancer treatment options.